Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Yearly Tax Loss Harvesting Etfs describes a disciplined annual approach to harvest losses and refresh positions efficiently.
13,404 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Investors are buzzing about Oklo as the Aurora Powerhouse regulatory path becomes clearer. This piece breaks down wha...
Alumis stock over 300% has turned heads after a big healthcare investor trimmed its stake. This article breaks down w...
Oklo stock just popped on news that the Department of Energy opened talks with multiple firms. This article breaks do...
The company behind Claude just filed for an IPO, stirring questions about AI stocks and long-term growth. This guide ...
SpaceX's IPO hype is hard to ignore, but there are four solid concerns investors should weigh before buying in. This ...
When top investors recalibrate, markets watch closely. This piece unpacks why the billionaire Griffin sold Amazon and...
Micron Technology surged to a fresh all-time high after a blockbuster earnings report and strong AI-driven demand. Th...
A little-known aerospace stock has delivered a blistering 470% gain over five years and recently reached a fresh all-...
Is a $5 trillion Apple valuation possible by the end of 2026? This guide weighs the growth engines, risks, and action...
Two prominent analysts lifted price targets on Newell Brands, sparking a rally where the stock raced higher. This art...
A growing platform rolls out an AI tool that lets users convert ideas into investable indices, with an uncapped 1% ma...